Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Phase II Trial of a Peptide Vaccine, Ocv-501 in Elderly Patients with Acute Myeloid Leukemia

Masaki Yamaguchi, MD PhD, Naoki Takezako, MD PhD, Toru Kiguchi, MD PhD, Shuichi Miyawaki, MD PhD, Yuji Heike, MD PhD, Kaori Mitsuki, Takahiro Yoshida, PhD, Ei Leen Liew, PhD MS, Tomoki Naoe, MD PhD

Blood (2018) 132 (Supplement 1): 29.

https://doi.org/10.1182/blood-2018-99-110013

Published: 2018

Journal Articles

A New Peptide Vaccine Ocv-501, Phase 1 Study in Patients with Acute Myeloid Leukemia and In Vitro Pharmacology

Tohru Sakura, MD, Yukio Kobayashi, MD PhD, Shuichi Miyawaki, MD PhD, Kazuyuki Toga, MS, Shinji Sogo, PhD, Yuji Heike, MD PhD

Blood (2016) 128 (22): 1643.

https://doi.org/10.1182/blood.V128.22.1643.1643

Published: 2016

Journal Articles

Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS)

Shigesaburo Miyakoshi, MD PhD, Kensuke Usuki, MD PhD, Itaru Matsumura, MD PhD, Yasunori Ueda, MD PhD, Hiromi Iwasaki, MD PhD, Toshihiro Miyamoto, MD PhD, Makoto Origuchi, Shuzo Tagashira, Ichiro Naoi, Tomoki Naoe, MD PhD, Masahiro Kizaki, MD PhD, Yuji Heike, MD PhD, Koichi Akashi, MD PhD, Yasushi Miyazaki, MD PhD

Blood (2016) 128 (22): 4335.

https://doi.org/10.1182/blood.V128.22.4335.4335

Published: 2016

Journal Articles

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

Nobuhiro Hiramoto, MD, Kinuko Tajima, Saiko Kurosawa, MD, Takuya Yamashita, MD, Kenji Okinaka, MD, Noriyuki Morikawa, MD, Kohei Tada, MD, Takashi Tanaka, MD, Ryosuke Ueda, MD, Yujin Kobayashi, MD, Akihito Shinohara, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Yuji Heike, MD, Takahiro Fukuda, MD

Blood (2011) 118 (21): 2033.

https://doi.org/10.1182/blood.V118.21.2033.2033

Published: 2011

Journal Articles

A Novel Enumeration Method for Hematopoietic Progenitor Cells in Collecting Peripheral Blood Stem Cell for Transplantation

Ryuji Tanosaki, M.D., Tomoko Kumazawa, M.T., Shigehisa Yoshida, M.T., Atsuya Nakano, M.T., Shizuka Yamagata, M.T., Noriko Takahashi, M.T., Saiko Kurosawa, MD, Shin-Ichiro Mori, M.D., Yuji Heike, MD, Takahiro Fukuda, MD, Ko Furuta, M.D., Hitoshi Tsuda, M.D.

Blood (2011) 118 (21): 1922.

https://doi.org/10.1182/blood.V118.21.1922.1922

Published: 2011

Journal Articles

Immunochromatography Method Was Useful in Prompt Diagnosis of Potentially Fatal Norovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation

Ryosuke Ueda, MD, Nobuhiro Hiramoto, MD, Shin-Ichiro Mori, MD, Saiko Kurosawa, MD, Takashi Tanaka, MD, Kohei Tada, MD, Yujin Kobayashi, MD, Noriyuki Morikawa, MD, Akihito Shinohara, MD, Keiji Okinaka, MD, Takuya Yamashita, MD, Yuji Heike, MD, Takahiro Fukuda, MD

Blood (2011) 118 (21): 4542.

https://doi.org/10.1182/blood.V118.21.4542.4542

Published: 2011

Journal Articles

Comparison of Outcomes After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) In 73 Patients with Follicular Lymphoma (FL), Transformed Follicular Lymphoma (TL), or De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Favorable Outcome for TL Similar to FL

Kohei Tada, MD, Sung-Won Kim, MD, Yoshitaka Asakura, MD, Nobuhiro Hiramoto, MD, Kimikazu Yakushijin, MD, Saiko Kurosawa, MD, Niina Ueno, MD, Yutaro Kamiyama, MD, Suguru Fukuhara, MD, Shinichiro Mori, MD, Yuji Heike, MD, Ryuji Tanosaki, MD, Kensei Tobinai, MD, Yoichi Takaue, MD, Takahiro Fukuda, MD

Blood (2010) 116 (21): 3508.

https://doi.org/10.1182/blood.V116.21.3508.3508

Published: 2010

Journal Articles

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

Takeshi Maeda, MD, Kimikazu Yakushijin, MD, Yoshitaka Asakura, MD, Nobuhiro Hiramoto, MD, Saiko Kurosawa, MD, Yutaro Kamiyama, MD, Suguru Fukuhara, MD, Niina Ueno, MD, Sung-Won Kim, MD, Shin-Ichiro Mori, MD, Ryuji Tanosaki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Yoichi Takaue, MD, Takahiro Fukuda, MD

Blood (2010) 116 (21): 2318.

https://doi.org/10.1182/blood.V116.21.2318.2318

Published: 2010

Journal Articles

Renal Complications after Busulfan-Based Reduced-Intensity Stem Cell Transplantation in 286 Patients with Hematological Disorders.

Kimikazu Yakushijin, Takahiro Fukuda, Yoshitaka Asakura, Saiko Kurosawa, Nobuhiro Hiramoto, Daisuke Nakamura, Kohei Tada, Masaaki Nishinohara, Akihito Hagiwara, Niina Ueno, Yutaro Kamiyama, Masakazu Mori, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Yoichi Takaue

Blood (2009) 114 (22): 3353.

https://doi.org/10.1182/blood.V114.22.3353.3353

Published: 2009

Journal Articles

Long-Term Outcome of ATL Patients Who Underwent Reduced-Intensity Stem Cell Transplantation (RIST): Suggested Potent Graft-Versus-ATL and HTLV-1 Effects.

Ryuji Tanosaki, Kimikazu Yakushijin, Yoshitaka Asakura, Saiko Kurosawa, Nobuhiro Hiramoto, Masakazu Mori, Takahiro Fukuda, Sung-Won Kim, Shin-ichiro Mori, Yuji Heike, Kensei Tobinai, Yoichi Takaue

Blood (2009) 114 (22): 3370.

https://doi.org/10.1182/blood.V114.22.3370.3370

Published: 2009

Journal Articles

Evaluation of Potential role for Valproic Acid in IL-3-Mediated Megakaryopoiesis and Erythropoiesis in Serum-Free and Serum-Containing Cultures.

Kohshi Ohishi, MD, PhD, Bing Liu, Masahiro Masuya, Yuji Heike, MD, PhD, Yoichi Takaue, Naoyuki Katayama, MD, PhD

Blood (2009) 114 (22): 2746.

https://doi.org/10.1182/blood.V114.22.2746.2746

Published: 2009

Journal Articles

HDAC Inhibitors, FK228 and Valproic Acid, Enhance the Effects of IL-3 or GMCSF on the Generation of Early Megakaryocytic as Well as Erythroid Precursors from Human Hematopoietic Precursors

Kohshi Ohishi, MD, PhD, Hyou Ryuu, MD, Kentaro Yamamura, MD, PhD, Masahiro Masuya, MD, PhD, Yuji Heike, MD, PhD, Yoichi Takaue, MD, Naoyuki Katayama, MD, PhD

Blood (2008) 112 (11): 5397.

https://doi.org/10.1182/blood.V112.11.5397.5397

Published: 2008

Journal Articles

Low-Dose ATG-F Reduces Non-Relapse Mortality after Reduced-Intensity Bone Marrow Transplantation from an Unrelated Donor: A Single-Center Analysis of 65 Patients.

Shigeo Fuji, Takahiro Fukuda, Sung-Won Kim, Eiji Usui, Saiko Kurosawa, Hiroki Yokoyama, Bungo Saito, Toshihiro Takahashi, Shin-ichiro Mori, Yuji Heike, Kensei Tobinai, Ryuji Tanosaki, Yoichi Takaue

Blood (2007) 110 (11): 5070.

https://doi.org/10.1182/blood.V110.11.5070.5070

Published: 2007

Journal Articles

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Shigeo Fuji, MD, Sung-Won Kim, MD, Takahiro Fukuda, MD, Shin-ichiro Mori, MD, Satoshi Yamasaki, MD, Yuriko Morita-Hoshi, MD, Fusako Ohara-Waki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD

Blood (2007) 110 (11): 1968.

https://doi.org/10.1182/blood.V110.11.1968.1968

Published: 2007

Journal Articles

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Bungo Saito, MD, Takahiro Fukuda, MD, Hiroki Yokoyama, MD, Saiko Kurosawa, MD, Toshihiro Takahashi, MD, Shigeo Fuji, MD, Noriko Takahashi, Kinuko Tajima, PhD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD, Yuji Heike, MD

Blood (2007) 110 (11): 2009.

https://doi.org/10.1182/blood.V110.11.2009.2009

Published: 2007

Journal Articles

Efficient Expansion of Lymphocytes in a Culture System with Solid Phase Anti-CD3 and Anti-CD28 Monoclonal Antibodies.

Atsuko Soeda, Atsushi Kondo, Hiroaki Makiyama, Yuriko Morita, Noriko Takahashi, Hideo Yagita, Yoichi Takaue, Yuji Heike

Blood (2006) 108 (11): 3648.

https://doi.org/10.1182/blood.V108.11.3648.3648

Published: 2006

Journal Articles

Serum Amyloid A (SAA) as a Molecular Marker for Pre-Engraftment Immune Reactions (PIR) after Cord Blood Transplantation.

Yuriko Morita-Hoshi, Yuji Heike, Yuka Ohsaki, Mieko Shiwa, Kazuhiro Masuoka, Atsushi Wake, Shuichi Taniguchi, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 3127.

https://doi.org/10.1182/blood.V108.11.3127.3127

Published: 2006

Journal Articles

Imaging the Differential Engraftment of GFP-Expressing Spleen and Bone Marrow Cells in Various Organs after Reduced-Intensity Stem Cell Transplantation in Mice Model.

Yuji Heike, MD, PhD, Zhijian Yang, PhD, Huaiyu Ma, PhD, Robert Hoffmann, PhD, Yuriko Morita, MD, Atsuko Soeda, MD, Hiroaki Makiyama, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2006) 108 (11): 3228.

https://doi.org/10.1182/blood.V108.11.3228.3228

Published: 2006

Journal Articles

Age-Related Risk of Non-Relapse Mortality Associated with Acute Graft-Versus-Host Disease.

Takahiro Fukuda, Yukiko Iisaka, Fusako Ohara, Atsushi Fujieda, Satoshi Yamasaki, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 40.

https://doi.org/10.1182/blood.V108.11.40.40

Published: 2006

Journal Articles

Impact of Hepatic Toxicities on Survival after Allogeneic Hematopoietic Cell Transplantation (HCT): Comparison of Reduced-Intensity Versus Conventional Conditioning Regimens at a Single Center.

Atsushi Fujieda, Takahiro Fukuda, Fusako Ohara, Satoshi Yamasaki, Sungwon Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 2976.

https://doi.org/10.1182/blood.V108.11.2976.2976

Published: 2006

NARROW

Phase II Trial of a Peptide Vaccine, Ocv-501 in Elderly Patients with Acute Myeloid Leukemia

A New Peptide Vaccine Ocv-501, Phase 1 Study in Patients with Acute Myeloid Leukemia and In Vitro Pharmacology

Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS)

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

A Novel Enumeration Method for Hematopoietic Progenitor Cells in Collecting Peripheral Blood Stem Cell for Transplantation

Immunochromatography Method Was Useful in Prompt Diagnosis of Potentially Fatal Norovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation

Comparison of Outcomes After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) In 73 Patients with Follicular Lymphoma (FL), Transformed Follicular Lymphoma (TL), or De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Favorable Outcome for TL Similar to FL

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

Renal Complications after Busulfan-Based Reduced-Intensity Stem Cell Transplantation in 286 Patients with Hematological Disorders.

Long-Term Outcome of ATL Patients Who Underwent Reduced-Intensity Stem Cell Transplantation (RIST): Suggested Potent Graft-Versus-ATL and HTLV-1 Effects.

Evaluation of Potential role for Valproic Acid in IL-3-Mediated Megakaryopoiesis and Erythropoiesis in Serum-Free and Serum-Containing Cultures.

HDAC Inhibitors, FK228 and Valproic Acid, Enhance the Effects of IL-3 or GMCSF on the Generation of Early Megakaryocytic as Well as Erythroid Precursors from Human Hematopoietic Precursors

Low-Dose ATG-F Reduces Non-Relapse Mortality after Reduced-Intensity Bone Marrow Transplantation from an Unrelated Donor: A Single-Center Analysis of 65 Patients.

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Efficient Expansion of Lymphocytes in a Culture System with Solid Phase Anti-CD3 and Anti-CD28 Monoclonal Antibodies.

Serum Amyloid A (SAA) as a Molecular Marker for Pre-Engraftment Immune Reactions (PIR) after Cord Blood Transplantation.

Imaging the Differential Engraftment of GFP-Expressing Spleen and Bone Marrow Cells in Various Organs after Reduced-Intensity Stem Cell Transplantation in Mice Model.

Age-Related Risk of Non-Relapse Mortality Associated with Acute Graft-Versus-Host Disease.

Impact of Hepatic Toxicities on Survival after Allogeneic Hematopoietic Cell Transplantation (HCT): Comparison of Reduced-Intensity Versus Conventional Conditioning Regimens at a Single Center.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only